CV prognosis good at six months after hospitalization for MIS-C

(HealthDay)—Children with multisystem inflammatory syndrome in children (MIS-C) treated with immunomodulators have favorable outcomes at six months, with normalization of left ventricular (LV) systolic function and resolution of coronary abnormalities, according to a study published online July 29 in Pediatrics. Christine A. Capone, M.D., M.P.H., from the Cohen Children’s Medical…

Are ‘immunity passports’ a good idea?

Vaccinations against COVID-19 are getting underway in England and will soon follow elsewhere. This is great news, but just the start of a long program that could extend well into the middle of 2021—and beyond. In the meantime, the number of people protected from symptomatic COVID will steadily grow as…

Mom and baby share ‘good bacteria’ through breast milk

A new study by researchers at the University of British Columbia and the University of Manitoba has found that bacteria are shared and possibly transferred from a mother’s milk to her infant’s gut, and that breastfeeding directly at the breast best supports this process. The research, published today in Cell…